DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,010
+10 (0.09%)
At close: Aug 12, 2026

DAE HWA Pharmaceutical Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
5,4921,3571,6584,3503,1254,002
Short-Term Investments
3,3003,3005,1007,6203,24011,340
Trading Asset Securities
1,7341,4451,1041,4891,5973,080
Cash & Short-Term Investments
10,5256,1027,86313,4587,96218,422
Cash Growth
61.54%-22.39%-41.58%69.03%-56.78%49.05%
Accounts Receivable
20,15319,30620,38322,75518,13716,719
Other Receivables
840.11966.011,0061,4221,3131,517
Receivables
20,99320,27221,38924,17619,45018,236
Inventory
34,62435,18331,34026,67823,41318,682
Prepaid Expenses
536.98669.01480.34310.27294.59287.91
Other Current Assets
90.2132.6534.76597.2392.92511.03
Total Current Assets
66,77062,35961,60765,22051,21356,139
Property, Plant & Equipment
87,78688,84791,70294,35189,85768,245
Long-Term Investments
12,0974,8693,79810,92910,4758,639
Goodwill
693.16693.16693.16693.16693.16693.16
Other Intangible Assets
29,56029,60828,63027,82226,97223,775
Long-Term Deferred Tax Assets
5,5664,5803,6223,9923,6424,172
Other Long-Term Assets
19,85519,90815,83116,15416,20415,713
Total Assets
222,327210,863205,884219,163199,056177,376

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
12,36813,58811,59715,78312,9258,026
Accrued Expenses
2,7842,6592,5592,6692,9581,504
Short-Term Debt
65,75161,62859,19974,45759,05556,347
Current Portion of Long-Term Debt
29,93931,19534,23828,1893,2502,500
Current Portion of Leases
130.68122.61117.78149.65201.76238.02
Current Income Taxes Payable
384.53231.246.2627.35380.051,463
Current Unearned Revenue
42.3542.3542.3542.3550.1969.05
Other Current Liabilities
13,63812,0199,8936,6314,4405,189
Total Current Liabilities
125,037121,484117,693127,94883,26075,335
Long-Term Debt
5,3063,6905,5667,50027,30710,796
Long-Term Leases
154.12139.96151.94229.92251.93269.24
Pension & Post-Retirement Benefits
4,0653,7263,7703,6763,2754,402
Other Long-Term Liabilities
2,7082,6822,3342,4573,2713,157
Total Liabilities
137,270131,722129,515141,809117,36593,960

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
9,3089,3089,3089,3089,3089,308
Additional Paid-In Capital
40,38135,55633,02333,02333,02333,023
Retained Earnings
36,30238,31939,38341,56245,86246,529
Treasury Stock
-1,618-7,573-9,162-9,162-9,162-9,162
Comprehensive Income & Other
-4,365-1,537-554.04-1,500-1,040-24.6
Total Common Equity
80,00874,07371,99973,23277,99379,674
Minority Interest
5,0495,0694,3714,1213,6993,742
Shareholders' Equity
85,05779,14276,37077,35381,69183,416
Total Liabilities & Equity
222,327210,863205,884219,163199,056177,376

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
101,28196,77699,274110,52590,06670,150
Net Cash (Debt)
-90,755-90,674-91,411-97,067-82,104-51,728
Net Cash Growth
------
Net Cash Per Share
-5125.09-5172.72-5160.42-5541.39-4687.19-2962.69
Filing Date Shares Outstanding
17.917.917.5217.5217.5217.52
Total Common Shares Outstanding
17.917.917.5217.5217.5217.52
Working Capital
-58,267-59,125-56,085-62,728-32,047-19,196
Book Value Per Share
4469.314137.764110.334180.704452.484548.48
Tangible Book Value
49,75543,77142,67644,71750,32755,206
Tangible Book Value Per Share
2779.362445.092436.302552.812873.103151.65
Land
-15,65918,96419,09719,09719,097
Buildings
-66,86567,44067,14445,06545,065
Machinery
-69,55462,37156,98342,93644,633
Construction In Progress
-847.17470.042,76529,5493,035